Product development is a plausible growth driver for EBM Technologies, as it reinvests over one-third of its revenue into in-house R&D and its mobile and AI imaging milestones include the 2020 U.S. FDA Class II medical device clearance for the UDE mobile medical imaging server app, though continued product adoption would be needed to confirm commercial impact.
In 2024, UDE and the Medical Imaging AI Integration Platform received the National Innovation Award for Continued Advancement.
2Memo
EBM Technologies can build on its PACS footprint as medical imaging informatics grows, provided its R&D sustains differentiated products and hospitals continue adopting them; established imaging vendors' modality bundles are a risk to independent PACS demand, and the company reports that over 2,000 hospitals worldwide work with its PACS software. It reinvests over one-third of revenue into in-house R&D. SoliPACS products use shared converters that store image files for access through the SoliPACS viewer and reporting features.
A 2026 medical imaging informatics report puts global spend at US$4.8 billion in 2026 and projects a 7.5% compound annual growth rate to roughly US$6.5 billion by 2030.
3Product Overview
SoliPACS unites radiology, mammography, and dental imaging in an integrated suite for healthcare institutions.
SoliPACS products store image files through shared SignalGate, FileGate, or CamGate converters, making them viewable in the SoliPACS client viewer, web viewer, and reporting tools.